Vodafone Group Plc Transaction in Own Shares

RNS Number : 3398M

Vodafone Group Plc

15 November 2024

 

VODAFONE GROUP PLC

 

TRANSACTIONS IN OWN SECURITIES

 

 

15 November 2024

 

 

Vodafone Group Plc ("Vodafone") announces today that it has purchased the following number of its ordinary shares of US$0.20 each from Citigroup Global Markets Limited ("Citi"). Such purchase was effected pursuant to instructions issued by Vodafone on 14 November 2024, as announced on 14 November 2024 (the "Programme"):

 

 

Date of purchase:	14 November 2024
Number of ordinary shares purchased:	17,775,900
Highest price paid per share (pence):	69.60
Lowest price paid per share (pence):	68.64
Volume weighted average price paid per share (pence):	69.28

 

 

Vodafone intends to hold the purchased shares in treasury. Following the purchase of these shares, Vodafone holds 2,238,843,995 of its ordinary shares in treasury and has 25,969,100,822 ordinary shares in issue (excluding treasury shares).

 

As part of the Programme, Citi purchases Vodafone (213800TB53ELEUKM7Q61) ordinary shares and sells such shares to Vodafone. In connection with the above purchases, on 14 November 2024 Citi (as riskless principal) elected to purchase 17,775,900 Vodafone ordinary shares to sell to Vodafone. A schedule of individual trades carried out by Citi on 14 November 2024 is set out below.

 

Schedule of purchases - aggregate information

 

Trading venue	Volume weighted average price (pence per share)	Aggregated volume
XLON	69.27	12,775,900
CHIX	-	-
BATS	69.30	5,000,000

 

http://www.rns-pdf.londonstockexchange.com/rns/3398M_1-2024-11-14.pdf

This announcement will also be available on Vodafone's website.

 

For more information, please contact:

 

Investor Relations:

 

investors.vodafone.com

 

[e-mail]

 

Media Relations:

 

Vodafone.com/media/contact

 

[e-mail]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSFFIFULELSELF